Skip to search formSkip to main contentSkip to account menu

(dApT)

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all…
2019
2019
After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo
Question After percutaneous coronary intervention (PCI) and 3 months of dual-antiplatelet therapy (DAPT), is P2Y12-inhibitor… 
Review
2018
Review
2018
Antiplatelet Therapy in Coronary Artery Disease: A Daunting Dilemma
Percutaneous coronary intervention (PCI) with stenting for the treatment of acute coronary syndrome (ACS) is the contemporary… 
2018
2018
Rationale and design of the EVOLVE Short DAPT Study to assess 3‐month dual antiplatelet therapy in subjects at high risk for bleeding undergoing percutaneous coronary intervention
2018
2018
Validation of DAPT Score (Dual Antiplatelet Therapy) in East Asian Patients
Article, see p 551 In this issue of Circulation , Yoshikawa et al1 provide important information about the validity of the DAPT… 
2018
2018
Return of Oral Anticoagulation in Chronic Stable Coronary Disease.
Antithrombotic therapy has been a cornerstone of secondary prevention for coronary artery disease (CAD) for the last 65 years… 
2017
2017
Effect of Yiqihuoxue prescription on myocardial energy metabolism after myocardial infarction via cross talk of liver kinase B1-dependent Notch1 and adenosine 5'-monophosphate-activated protein…
2017
2017
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer…
Review
2017
Review
2017
Efficacy and Safety of Novel Oral P2Y12 Receptor Inhibitors in Patients With ST-Segment Elevation Myocardial Infarction Undergoing PCI: A Systematic Review and Meta-Analysis
Abstract:The efficacy and safety of novel oral P2Y12 receptor inhibitors (prasugrel and ticagrelor) are subjects of contention in… 
Review
2015
Review
2015
Commentary on the OPTIDUAL trial results: how to optimise prolonged dual antiplatelet treatment and independent randomised clinical trials.
This editorial refers to ‘Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)